|
|
| Sept. 7 | No Seminar-- School of Pharmacy and Pharmaceutical Sciences picnic |
| Sept. 14 | No Seminar- |
| Sept. 21 | Don Mager, Pharmaceutical Sciences Graduate Student, UB, Receptor-Mediated Pharmacokinetics and Pharmacodynamics of Interferon-beta in Monkeys |
| Sept. 28 | Joe Raybon, CDDET Graduate Student, UB Evaluation of the Brain Efflux Index Method; To BEI
or not to BEI |
| Oct. 5 | Elzbieta Wyska, Post-Doctoral Fellow, UB, The Role of Unbound Imipramine Serum Concentration Monitoring in the Management of Major Depression |
| Oct. 12 | Dr. Kathleen Boje and Dr. Saucinuac, Pharmaceutical Sciences Faculty, the Virtual Laboratory |
| Oct. 19 | Ellen Wang, Pharmaceutical Sciences Graduate Student, UB Factors Affecting the Pharmacodynamic Tolerance of Nitroglycerin |
| Oct. 26 | Dr. George DeTitta, Executive VP, Hauptman-Woodward Proteonomics and Bioinformatics: Impact on Drug Discovery |
| Nov. 2 | No Seminar-- AAPS Meetings |
| Nov. 9 | Rohini Ramakrishnan, Pharmaceutical Sciences Graduate Student, UB Receptor Mediated Pharmacodynamics of Methylprednisolone During Seven-Day Infusion in Rats |
| Nov. 16 | Dr. Saeho Chong, Scientist, BMS PgP and Drug Absorption |
| Nov. 23 | No Seminar-- Thanksgiving |
| Nov. 30 | Dr. Philip LoVerde, Professor Microbio Molecular and Immunologic Investigation of Schistosomiasis |
| Dec. 7 | Dr. Steven LaTrent, Scientist, BMS, PK/PD in the Development of Cancer Chemotherapeutics</td>
|
| Dec. 14 | No Seminar-- Winter Break |
| Dec. 21 | No Seminar-- Winter Break |
| Dec. 28 | No Seminar-- Winter Break |
| Jan. 4 | No Seminar-- Winter Break |
| Jan. 11 | No Seminar-- Winter Break |
| Jan. 18 | Ryan Hansen, Pharmaceutical Sciences Graduate Student, UB Investigations on the Mechanism of IVIG Action in ITP |
| Jan. 25 | Robert Arnold, Graduate Student, UB Title to be announced |
| Feb. 1 | Dr. Patrick Smith, Faculty PP/RPCI Pharmacokinetics/Pharmacodynamics of Anti-Retroviral Agents |
| Feb. 8 | Evelyn Lobo, Pharmaceutical Sciences Graduate Student, UB PK/PD-Based Selection of Optimal Dosing Strategies for Ovarian Cancer
|
| Feb. 15 | Dr. Dan Brazaeu, Pharmaceutical Sciences Faculty, UB Capabilities of the Pharmaceutics Genetic Laboratory |